Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (DRKS00041567) titled 'Dynamic microbiome and bacterial metabolite analysis in patients with advanced HCC undergoing immunotherapy' on Sept. 9.
Study Type: observational
Study Design:
Allocation:
Masking:
Control:
Assignment:
Study design purpose: basic science
Primary Sponsor: Universitaetsklinikum Tuebingen
Condition:
C22.0
Malignant neoplasm: Liver cell carcinoma
Intervention:
Group 1: This is a prospective observational multi-center clinical study.
Blood samples of 20 ml (10 ml EDTA, 10 ml Serum) will be collected at the following visits:
* Baseline, before the first application of the ICI
* Before application of cycles 2, 3...